Given the diversity
of clinical and pathological aspects of
non-Hodgkin’s lymphomas, as many data as possible
are needed for a positive diagnosis. The quality of
bioptic material is one of the most important
factors involved in specific investigations and for
obtaining pathological, immunohistochemical,
molecular biology and cytogenetic data. The
correlation of these data obtained from bioptic
material helps the positive diagnosis of the patient
in order to design an individualized treatment.
Key words: non-hodgkin s
lymphoma, cancer, genetics.